Document Detail

Use of depot medroxyprogesterone acetate and fracture risk.
MedLine Citation:
PMID:  20685865     Owner:  NLM     Status:  MEDLINE    
CONTEXT: Depot medroxyprogesterone acetate (DMPA), which has a high rate of use among teenagers in Europe and the United States, has been associated with impaired bone mineral acquisition during adolescence and accelerated bone loss in later life. Studies on the association between DMPA use and fracture risk are limited.
OBJECTIVE: We aimed at evaluating the relationship between use of hormonal contraceptives, specifically DMPA, and fracture risk.
DESIGN: We conducted a case-control analysis using the United Kingdom-based General Practice Research Database.
SETTING AND PARTICIPANTS: Participants were females aged 20-44 yr with an incident fracture diagnosis between 1995 and 2008.
MAIN OUTCOME MEASURES: Odds ratios (OR) with 95% confidence intervals (CI) of incident fracture in relation to exposure to DMPA or combined oral contraceptives were assessed. Adjustments were made for smoking, body mass index, and additional potential confounders.
RESULTS: We identified 17,527 incident fracture cases and 70,130 control patients (DMPA exposure: 11 and 8%, respectively). Compared with nonuse, current use of one to two, three to nine, or 10 or more DMPA prescriptions yielded adjusted OR for fractures of 1.18 (95% CI = 0.93-1.49), 1.36 (95% CI = 1.15-1.60), and 1.54 (95% CI = 1.33-1.78), respectively. Fracture risk was highest after longer treatment duration (>2-3 yr), and there was no difference in patients below and above the age of 30 yr. For users of combined estrogen-containing oral contraceptives, the OR were around 1.
CONCLUSIONS: This population-based study suggests that use of DMPA is associated with a slightly increased risk of fractures.
Christian Meier; Yolanda B Brauchli; Susan S Jick; Marius E Kraenzlin; Christoph R Meier
Related Documents :
18922215 - Relationship between duration of compliant bisphosphonate use and the risk of osteoporo...
15276595 - Serum vitamin a concentration and the risk of hip fracture among women 50 to 74 years o...
11043875 - Balance function and fall-related efficacy in patients with newly operated hip fracture.
19470635 - A cohort study of thiazolidinediones and fractures in older adults with diabetes.
9160935 - Interlocking intramedullary nailing with and without reaming for the treatment of close...
12095725 - The role of laser doppler flowmetry in assessing the viability of bone fragments in an ...
Publication Detail:
Type:  Journal Article     Date:  2010-08-04
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  95     ISSN:  1945-7197     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-05     Completed Date:  2010-12-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  United States    
Other Details:
Languages:  eng     Pagination:  4909-16     Citation Subset:  AIM; IM    
Division of Endocrinology, Diabetes, and Metabolism, University Hospital Basel, Basel, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bone Density / drug effects*
Contraceptive Agents, Female / administration & dosage,  adverse effects
Fractures, Bone / epidemiology*,  etiology*
Medroxyprogesterone Acetate / administration & dosage,  adverse effects*
Odds Ratio
Reg. No./Substance:
0/Contraceptive Agents, Female; 71-58-9/Medroxyprogesterone Acetate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Adiponectin gene polymorphisms are associated with long-chain ?3-polyunsaturated fatty acids in seru...
Next Document:  Cholesterol Biosynthesis Pathway Intermediates and Inhibitors Regulate Glucose-Stimulated Insulin Se...